This observational study evaluated the prognostic value of a composite biomarker comprising serum zinc levels, selenoprotein P (SELENOP), and patient age in predicting survival among hospitalized COVID-19 patients. Conducted in Germany, the study included 35 patients with confirmed SARS-CoV-2 infection. Findings revealed that non-survivors had significantly lower levels of zinc
